肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

高碳水化合物饮食与结直肠癌无独立相关性

2012-03-21 MedSci MedSci原创

结直肠癌
关注

　《癌症病因和控制》（Cancer Causes and Control）杂志3月15日在线发表的一项荟萃分析结果不支持高碳水化合物、血糖指数或血糖负荷饮食与结直肠癌风险具有独立相关性。 　　该研究搜索了PubMed数据库2011年10月以前关于碳水化合物、血糖指数和血糖负荷与结直肠癌风险的前瞻性研究，并进行评估。 　　结果显示，共有14项前瞻性队列研究可评估。

　《癌症病因和控制》（Cancer Causes and Control）杂志3月15日在线发表的一项荟萃分析结果不支持高碳水化合物、血糖指数或血糖负荷饮食与结直肠癌风险具有独立相关性。

　　该研究搜索了PubMed数据库2011年10月以前关于碳水化合物、血糖指数和血糖负荷与结直肠癌风险的前瞻性研究，并进行评估。

　　结果显示，共有14项前瞻性队列研究可评估。

　　碳水化合物、血糖指数和血糖负荷饮食摄入量最高 vs. 最低者的结直肠癌总体相对风险（RR）分别为1.00、1.07和1.00。

　　量效分析显示， 每日摄入100g碳水化合物、每10个单位血糖指数和每50个单位血糖负荷的总体RR分别为0.95、1.07和1.01。

　　PubMed链接：Carbohydrates, glycemic index, glycemic load, and colorectal cancer risk: a systematic review and meta-analysis of cohort studies.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1740847, encodeId=29841e408475d, content=<a href='/topic/show?id=7b9a10252930' target=_blank style='color:#2F92EE;'>#高碳水化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102529, encryptionId=7b9a10252930, topicName=高碳水化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa34824892, createdName=ms7405317358118777, createdTime=Tue May 22 02:14:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906249, encodeId=d3d71906249d1, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Oct 13 15:14:00 CST 2012, time=2012-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837085, encodeId=f515183e08592, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Dec 27 08:14:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452574, encodeId=545714525e4dc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464335, encodeId=be8c146433598, content=<a href='/topic/show?id=9b04641580e' target=_blank style='color:#2F92EE;'>#水化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64158, encryptionId=9b04641580e, topicName=水化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1276671681, createdName=yuanming9, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=)]
    2012-05-22 ms7405317358118777

    #高碳水化合物#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1740847, encodeId=29841e408475d, content=<a href='/topic/show?id=7b9a10252930' target=_blank style='color:#2F92EE;'>#高碳水化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102529, encryptionId=7b9a10252930, topicName=高碳水化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa34824892, createdName=ms7405317358118777, createdTime=Tue May 22 02:14:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906249, encodeId=d3d71906249d1, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Oct 13 15:14:00 CST 2012, time=2012-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837085, encodeId=f515183e08592, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Dec 27 08:14:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452574, encodeId=545714525e4dc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464335, encodeId=be8c146433598, content=<a href='/topic/show?id=9b04641580e' target=_blank style='color:#2F92EE;'>#水化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64158, encryptionId=9b04641580e, topicName=水化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1276671681, createdName=yuanming9, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=)]
    2012-10-13 wangyang7958

    #化合物#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1740847, encodeId=29841e408475d, content=<a href='/topic/show?id=7b9a10252930' target=_blank style='color:#2F92EE;'>#高碳水化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102529, encryptionId=7b9a10252930, topicName=高碳水化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa34824892, createdName=ms7405317358118777, createdTime=Tue May 22 02:14:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906249, encodeId=d3d71906249d1, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Oct 13 15:14:00 CST 2012, time=2012-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837085, encodeId=f515183e08592, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Dec 27 08:14:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452574, encodeId=545714525e4dc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464335, encodeId=be8c146433598, content=<a href='/topic/show?id=9b04641580e' target=_blank style='color:#2F92EE;'>#水化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64158, encryptionId=9b04641580e, topicName=水化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1276671681, createdName=yuanming9, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=)]
    2012-12-27 shenxlcyp

    #相关性#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1740847, encodeId=29841e408475d, content=<a href='/topic/show?id=7b9a10252930' target=_blank style='color:#2F92EE;'>#高碳水化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102529, encryptionId=7b9a10252930, topicName=高碳水化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa34824892, createdName=ms7405317358118777, createdTime=Tue May 22 02:14:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906249, encodeId=d3d71906249d1, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Oct 13 15:14:00 CST 2012, time=2012-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837085, encodeId=f515183e08592, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Dec 27 08:14:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452574, encodeId=545714525e4dc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464335, encodeId=be8c146433598, content=<a href='/topic/show?id=9b04641580e' target=_blank style='color:#2F92EE;'>#水化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64158, encryptionId=9b04641580e, topicName=水化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1276671681, createdName=yuanming9, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=)]
    2012-03-23 crystal0564

    #结直肠#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1740847, encodeId=29841e408475d, content=<a href='/topic/show?id=7b9a10252930' target=_blank style='color:#2F92EE;'>#高碳水化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102529, encryptionId=7b9a10252930, topicName=高碳水化合物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fa34824892, createdName=ms7405317358118777, createdTime=Tue May 22 02:14:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906249, encodeId=d3d71906249d1, content=<a href='/topic/show?id=7795334e220' target=_blank style='color:#2F92EE;'>#化合物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33472, encryptionId=7795334e220, topicName=化合物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=267e204, createdName=wangyang7958, createdTime=Sat Oct 13 15:14:00 CST 2012, time=2012-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837085, encodeId=f515183e08592, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Dec 27 08:14:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1452574, encodeId=545714525e4dc, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464335, encodeId=be8c146433598, content=<a href='/topic/show?id=9b04641580e' target=_blank style='color:#2F92EE;'>#水化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64158, encryptionId=9b04641580e, topicName=水化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1276671681, createdName=yuanming9, createdTime=Fri Mar 23 12:14:00 CST 2012, time=2012-03-23, status=1, ipAttribution=)]
    2012-03-23 yuanming9

    #水化#

    0

相关资讯

2012年卫生部《结直肠癌诊疗质量控制指标（试行）》

 各省、自治区、直辖市卫生厅局，新疆生产建设兵团卫生局： 为规范我国结直肠癌诊疗行为，提高结直肠癌诊疗水平，改善结直肠癌患者预后，保障医疗质量和医疗安全，2010年10月，我部制订下发了《结直肠癌诊疗规范（2010年版）》（以下简称《规范》），并于2011年5月下发《卫生部办公厅关于开展结直肠癌病例信息登记工作的通知》（卫办医政函〔2011〕428号），在全国范围内开展结直肠癌诊疗病例

梭杆菌与结直肠癌存在神秘关联

　12月19日，美国《时代》周刊盘点2011年医学十大突破，其中，10月发表于《基因组研究》(Genome Research）的两项研究显示细菌与结肠癌之间存在神秘关联。一种名为“梭杆菌”的细菌平常很少出现在正常的人体肠道内，当科学家们将健康的结肠组织与癌变组织进行对比时注意到：这种细菌明显地集中并活跃于癌变组织中，在一部分样本中，这种差异甚至达到了上百倍。于是，人们首次开始思考：肠道菌

BJS：结直肠癌肝转移肝切除术后强化随访无益

　英国学者近期发表于《英国外科杂志》（British Journal of Surgery）的一项荟萃分析表明，关于结直肠癌肝转移肝切除术后随访研究的资料很少，早期强化随访未被发现可增加患者生存益处。 　　研究者系统回顾了2003年1月～2010年3月发表的文献，并进行了相关的研究分析。 　　结果显示，共有35项研究（包含7330例患者）被纳入分析，仅5项有专门的随访数据。 　　接受早期强

蔡三军：2011年结直肠癌外科治疗进展

　过去的一年里，结直肠癌领域又有许多新的进展出现，本文仅结合个人阅读的文献和自身体会，浅谈结直肠癌流行病学和外科领域去年的一些变化。 　　流行病学变化 　　近年来，随着国内生活方式的改变，结直肠癌的发病率逐年升高，但系统的流行病学资料多不完整。上海市2011年公布的流行病学资料显示：截止2008 年12月31日，上海市恶性肿瘤现有患者214091例，患病率为1.56%，其中乳腺癌（16.88％

李进：2011年晚期结直肠癌内科治疗进展

图 结肠癌血行转移  　　结直肠癌是全世界范围内最常见的恶性肿瘤之一。粗略统计每年约有120万新发结直肠癌病例，患者死亡率也占所有肿瘤的8%。虽然早期结直肠癌患者的5年生存率可达到 90%，但仍有很多患者在初诊时已属于中晚期阶段，而转移性结直肠癌患者的5年生存率仅为10%。近年来，各国学者围绕着如何改善结直肠癌患者生存展开了许多探索。本文将概述2011年晚期结直肠癌的内科治疗进展。

BMJ：28年随访：镁摄入量与结直肠癌无独立相关性

　　《英国癌症杂志》（British Journal of Cancer）3月13日在线发表的一项研究不支持镁摄入量与女性结直肠癌和血浆C肽水平独立相关的假说。 　　研究者评估了护士健康研究（NHS，该研究1980年起对85924名非癌症女性进行随访，直至2008年6月）镁摄入量与结直肠相关的假说，并采用Cox比例风险回归模型进行了相关的统计分析。 　　结果显示，